铁(Fe3+)依赖性端粒酶再激活驱动结直肠癌。

IF 29.7 1区 医学 Q1 ONCOLOGY Cancer discovery Pub Date : 2024-06-14 DOI:10.1158/2159-8290.CD-23-1379
Raghuvaran Shanmugam, Prativa Majee, Wei Shi, Mert Burak Ozturk, Thamil Selvan Vaiyapuri, Khaireen Idzham, Anandhkumar Raju, Seung Hee Shin, Kerem Fidan, Joo-Leng Low, Joelle Yi Heng Chua, Yap Choon Kong, Ong Yue Qi, Emile Tan, Aik Yong Chok, Isaac Seow-En, Ian Wee, Dominique Camat Macalinao, Dawn Qingqing Chong, Hong Yun Chang, Fiona Lee, Wei Qiang Leow, Maki Murata-Hori, Zhang Xiaoqian, Chia Shumei, Chris Soon Heng Tan, Ramanuj Dasgupta, Iain Beehuat Tan, Vinay Tergaonkar
{"title":"铁(Fe3+)依赖性端粒酶再激活驱动结直肠癌。","authors":"Raghuvaran Shanmugam, Prativa Majee, Wei Shi, Mert Burak Ozturk, Thamil Selvan Vaiyapuri, Khaireen Idzham, Anandhkumar Raju, Seung Hee Shin, Kerem Fidan, Joo-Leng Low, Joelle Yi Heng Chua, Yap Choon Kong, Ong Yue Qi, Emile Tan, Aik Yong Chok, Isaac Seow-En, Ian Wee, Dominique Camat Macalinao, Dawn Qingqing Chong, Hong Yun Chang, Fiona Lee, Wei Qiang Leow, Maki Murata-Hori, Zhang Xiaoqian, Chia Shumei, Chris Soon Heng Tan, Ramanuj Dasgupta, Iain Beehuat Tan, Vinay Tergaonkar","doi":"10.1158/2159-8290.CD-23-1379","DOIUrl":null,"url":null,"abstract":"<p><p>Over-consumption of iron-rich red meat and hereditary or genetic iron overload are associated with increased risk of colorectal carcinogenesis, yet the mechanistic basis of how metal-mediated signaling leads to oncogenesis remains enigmatic. Using fresh colorectal cancer (CRC) samples we identify Pirin, an iron sensor, that overcomes a rate-limiting step in oncogenesis, by re-activating the dormant human-reverse-transcriptase (hTERT) subunit of telomerase holoenzyme in an iron-(Fe3+)-dependent-manner and thereby drives CRCs. Chemical genetic screens combined with isothermal-dose response fingerprinting and mass-spectrometry identified a small molecule SP2509, that specifically inhibits Pirin-mediated hTERT reactivation in CRCs by competing with iron-(Fe3+) binding. Our findings, first to document how metal ions reactivate telomerase, provide a molecular mechanism for the well-known association between red meat, and increased incidence of CRCs. Small molecules like SP2509 represent a novel modality to target telomerase that acts as driver of 90% human cancers and is yet to be targeted in clinic.</p>","PeriodicalId":9430,"journal":{"name":"Cancer discovery","volume":null,"pages":null},"PeriodicalIF":29.7000,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Iron-(Fe3+) dependent reactivation of telomerase drives colorectal cancers.\",\"authors\":\"Raghuvaran Shanmugam, Prativa Majee, Wei Shi, Mert Burak Ozturk, Thamil Selvan Vaiyapuri, Khaireen Idzham, Anandhkumar Raju, Seung Hee Shin, Kerem Fidan, Joo-Leng Low, Joelle Yi Heng Chua, Yap Choon Kong, Ong Yue Qi, Emile Tan, Aik Yong Chok, Isaac Seow-En, Ian Wee, Dominique Camat Macalinao, Dawn Qingqing Chong, Hong Yun Chang, Fiona Lee, Wei Qiang Leow, Maki Murata-Hori, Zhang Xiaoqian, Chia Shumei, Chris Soon Heng Tan, Ramanuj Dasgupta, Iain Beehuat Tan, Vinay Tergaonkar\",\"doi\":\"10.1158/2159-8290.CD-23-1379\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Over-consumption of iron-rich red meat and hereditary or genetic iron overload are associated with increased risk of colorectal carcinogenesis, yet the mechanistic basis of how metal-mediated signaling leads to oncogenesis remains enigmatic. Using fresh colorectal cancer (CRC) samples we identify Pirin, an iron sensor, that overcomes a rate-limiting step in oncogenesis, by re-activating the dormant human-reverse-transcriptase (hTERT) subunit of telomerase holoenzyme in an iron-(Fe3+)-dependent-manner and thereby drives CRCs. Chemical genetic screens combined with isothermal-dose response fingerprinting and mass-spectrometry identified a small molecule SP2509, that specifically inhibits Pirin-mediated hTERT reactivation in CRCs by competing with iron-(Fe3+) binding. Our findings, first to document how metal ions reactivate telomerase, provide a molecular mechanism for the well-known association between red meat, and increased incidence of CRCs. Small molecules like SP2509 represent a novel modality to target telomerase that acts as driver of 90% human cancers and is yet to be targeted in clinic.</p>\",\"PeriodicalId\":9430,\"journal\":{\"name\":\"Cancer discovery\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":29.7000,\"publicationDate\":\"2024-06-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer discovery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1158/2159-8290.CD-23-1379\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer discovery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1158/2159-8290.CD-23-1379","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

过量食用富含铁的红肉以及遗传性或基因性铁超载与结直肠癌发生风险的增加有关,但金属介导的信号转导如何导致肿瘤发生的机理基础仍然是个谜。通过使用新鲜的结直肠癌(CRC)样本,我们发现了铁传感器 Pirin,它能以铁(Fe3+)依赖的方式重新激活端粒酶全酶中休眠的人类逆转录酶(hTERT)亚基,从而克服致癌过程中的限速步骤,并驱动 CRCs。化学遗传筛选与等温剂量反应指纹图谱和质谱分析相结合,发现了一种小分子 SP2509,它能通过与铁(Fe3+)结合竞争,特异性地抑制 Pirin 介导的 CRC 中 hTERT 的再激活。我们的发现首次记录了金属离子如何重新激活端粒酶,为众所周知的红肉与 CRC 发病率增加之间的联系提供了分子机制。像SP2509这样的小分子药物代表了一种靶向端粒酶的新方法,端粒酶是90%人类癌症的驱动因素,但在临床上尚未成为靶向药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Iron-(Fe3+) dependent reactivation of telomerase drives colorectal cancers.

Over-consumption of iron-rich red meat and hereditary or genetic iron overload are associated with increased risk of colorectal carcinogenesis, yet the mechanistic basis of how metal-mediated signaling leads to oncogenesis remains enigmatic. Using fresh colorectal cancer (CRC) samples we identify Pirin, an iron sensor, that overcomes a rate-limiting step in oncogenesis, by re-activating the dormant human-reverse-transcriptase (hTERT) subunit of telomerase holoenzyme in an iron-(Fe3+)-dependent-manner and thereby drives CRCs. Chemical genetic screens combined with isothermal-dose response fingerprinting and mass-spectrometry identified a small molecule SP2509, that specifically inhibits Pirin-mediated hTERT reactivation in CRCs by competing with iron-(Fe3+) binding. Our findings, first to document how metal ions reactivate telomerase, provide a molecular mechanism for the well-known association between red meat, and increased incidence of CRCs. Small molecules like SP2509 represent a novel modality to target telomerase that acts as driver of 90% human cancers and is yet to be targeted in clinic.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cancer discovery
Cancer discovery ONCOLOGY-
CiteScore
22.90
自引率
1.40%
发文量
838
审稿时长
6-12 weeks
期刊介绍: Cancer Discovery publishes high-impact, peer-reviewed articles detailing significant advances in both research and clinical trials. Serving as a premier cancer information resource, the journal also features Review Articles, Perspectives, Commentaries, News stories, and Research Watch summaries to keep readers abreast of the latest findings in the field. Covering a wide range of topics, from laboratory research to clinical trials and epidemiologic studies, Cancer Discovery spans the entire spectrum of cancer research and medicine.
期刊最新文献
Trem2-expressing multinucleated giant macrophages are a biomarker of good prognosis in head and neck squamous cell carcinoma NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations Increased RNA and protein degradation is required for counteracting transcriptional burden and proteotoxic stress in human aneuploid cells. Zongertinib (BI 1810631), an irreversible HER2 TKI, spares EGFR signaling and improves therapeutic response in preclinical models and patients with HER2-driven cancers. D3S-001, a KRAS G12C Inhibitor with Rapid Target Engagement Kinetics, Overcomes Nucleotide Cycling, and Demonstrates Robust Preclinical and Clinical Activities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1